Getinge AB (publ) (GNGBF)
- Previous Close
0.00 - Open
21.95 - Bid 17.75 x 40700
- Ask 19.85 x 38800
- Day's Range
21.55 - 21.95 - 52 Week Range
17.44 - 22.39 - Volume
200 - Avg. Volume
34 - Market Cap (intraday)
5.116B - Beta (5Y Monthly) 0.47
- PE Ratio (TTM)
34.12 - EPS (TTM)
0.59 - Earnings Date Oct 18, 2024
- Forward Dividend & Yield 0.40 (2.00%)
- Ex-Dividend Date Apr 23, 2024
- 1y Target Est
--
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, mechanical circulatory support, advanced patient monitoring, ICU infrastructure equipment, patient flow management, and drainage solutions. The company also provides surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, and drainage solutions; and operating room infrastructure equipment, anesthesia, advanced patient monitoring, operating room management, and operating room integration solutions. In addition, it offers pre-cleaning, cleaning and disinfection, sterilization, consumables, endoscope reprocessing, and sterile supply management solutions; connected medical devices; bioreactor systems, DPTE systems, Getinge isolators, terminal sterilization products, and sterilizers; and vivarium, biohazardous materials handling solutions, labware cleaning and sterilization, upstream bioprocessing, and bioreactor preparation solutions. It offers its products through a network of sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia and Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.
www.getinge.comRecent News: GNGBF
View MorePerformance Overview: GNGBF
Trailing total returns as of 10/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: GNGBF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: GNGBF
View MoreValuation Measures
Market Cap
5.12B
Enterprise Value
5.93B
Trailing P/E
34.30
Forward P/E
18.45
PEG Ratio (5yr expected)
1.58
Price/Sales (ttm)
1.73
Price/Book (mrq)
1.92
Enterprise Value/Revenue
1.87
Enterprise Value/EBITDA
12.15
Financial Highlights
Profitability and Income Statement
Profit Margin
5.03%
Return on Assets (ttm)
3.77%
Return on Equity (ttm)
5.45%
Revenue (ttm)
33.59B
Net Income Avi to Common (ttm)
1.69B
Diluted EPS (ttm)
0.59
Balance Sheet and Cash Flow
Total Cash (mrq)
2.24B
Total Debt/Equity (mrq)
35.67%
Levered Free Cash Flow (ttm)
3.86B